Landaas & CO Amgen Inc Transaction History

Landaas & CO

$327 Million
Q2 2024

A detailed history of Landaas & CO transactions in Amgen Inc stock. As of the latest transaction made, Landaas & CO holds 1,127 shares of AMGN stock, worth $355,613. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,127

Previous 1,750 35.6%

Holding current value

$355,613

Previous $497,000 29.18%

% of portfolio

0.11%

Previous 0.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $163,693 - $198,930	-623 Reduced 35.6%	1,127 $352,000
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $10,228 - $11,538	-40 Reduced 2.23%	1,750 $504,000
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $63,906 - $71,116	-277 Reduced 13.4%	1,790 $436,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $5,943 - $6,963	28 Added 1.37%	2,067 $440,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $132,036 - $153,867	595 Added 41.2%	2,039 $507,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $43,276 - $51,534	-200 Reduced 12.17%	1,444 $332,000
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $325,199 - $399,064	1,644 New	1,644 $388,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $299,602 - $397,354	-1,644 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $9,053 - $10,848	-52 Reduced 3.07%	1,644 $318,000
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $858,004 - $1.01 Million	-5,147 Reduced 75.22%	1,696 $313,000
Q1 2019 Apr 19, 2019	BUY	$180.87 - $203.88 $1.18 Million - $1.33 Million	6,521 Added 2025.16%	6,843 $322,000
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $257,378 - $290,121	-1,423 Reduced 81.55%	322 $322,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $6,777 - $7,920	40 Added 2.35%	1,745 $297,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $285,229 - $325,655	1,705	1,705 $318,000

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.

Account